January 2025 Update On GLP-1s, Semaglutide, and Tirzepatide – Monthly Mastermind January 2025, January Mastermind

Update On GLP-1s, Semaglutide, and Tirzepatide – Monthly Mastermind January 2025, January Mastermind

**NOTE** – Tesofensine was approved by the FDA as a part of Tesomet as an orphan drug designation. There is division among compounders regarding whether the orphan drug status allows Tesofensine to meet the requirements to compound with. Some say yes, and some say no. You will need to decide for your pharmacy.

Canva Template for Marketing
GLP-1 (Semaglutide) / Tesofensine – Template Graphics

You can purchase Tesofensine by contacting Jerry of Biopeptek.
Email him at jerry@biopeptek.com

Summary

Lisa Faast discussed the latest FDA updates on compounding and selling compounded semaglutide, emphasizing the uncertainty due to ongoing litigation. She highlighted the removal of trazodone from the FDA shortage list and the extension of enforcement discretion for compounding. Lisa introduced Tesla fencing as a cost-effective, oral peptide for weight loss, with a target dose of 0.5 mg, and discussed its benefits and side effects. She also stressed the importance of marketing compliance, suggested creating bundles for weight loss programs, and offered resources for custom marketing materials. The session concluded with a Q&A on sourcing GLP-1 analogs and Tesla fencing.

Action Items

Outline

FDA Updates and Introduction to the Meeting

Pharmacy Profit Matrix and Upcoming Events

FDA Status on Tricep Petite and Semaglutide

Introduction to Tesla Fencing

Marketing Strategies for Compounding

Vanity Services and Custom Marketing Materials

Q&A and Final Remarks

The meeting concludes with a reminder of available resources and support through daily implementation calls and office hours.

Lisa addresses questions from participants about Tesla fencing, including its availability and dosing.

She provides contact information for purchasing Tesla fencing from Bio Pep Tech.

Lisa encourages members to communicate with doctors about FDA guidelines and to explore alternative weight loss options.